Death with graft function after kidney transplantation: a single-center experience.

about

Death with graft function after kidney transplantation: a single-center experience.

Item

http://www.wikidata.org/entity/Q47211243

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Death with graft function after kidney transplantation: a single-center experience.

@en

Death with graft function after kidney transplantation: a single-center experience.

@nl

type

Item

label

Death with graft function after kidney transplantation: a single-center experience.

@en

Death with graft function after kidney transplantation: a single-center experience.

@nl

prefLabel

Death with graft function after kidney transplantation: a single-center experience.

@en

Death with graft function after kidney transplantation: a single-center experience.

@nl

P1476

Death with graft function after kidney transplantation: a single-center experience.

@en

P2093

Hajeong Lee

http://www.w3.org/2001/XMLSchema#string

Jung Pyo Lee

http://www.w3.org/2001/XMLSchema#string

Mi-Yeon Yu

http://www.w3.org/2001/XMLSchema#string

Yon Su Kim

http://www.w3.org/2001/XMLSchema#string

Yong Chul Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Factors influencing long-term outcome after kidney transplantation

OPTN/SRTR 2013 Annual Data Report: kidney.

Delayed graft function and the risk for death with a functioning graft.

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.

Epidemiology and unique aspects of aging and infectious diseases.

Identifying the patient at risk for post-transplant lymphoproliferative disorder.

Association of HLA mismatch with death with a functioning graft after kidney transplantation: a collaborative transplant study report.

Strategies to improve long-term outcomes after renal transplantation.

Immunosuppressant dose reduction and long-term rejection risk in renal transplant recipients with severe bacterial pneumonia

When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly.

P2888

s10157-017-1503-9

P304

710-718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10157-017-1503-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29159528

http://www.w3.org/2001/XMLSchema#string

P932

5956041

http://www.w3.org/2001/XMLSchema#string